DrugPatentWatch Database Preview

Details for Patent: 9,308,195

« Back to Dashboard

Which drugs does patent 9,308,195 protect, and when does it expire?

Patent 9,308,195 protects DOCETAXEL and is included in one NDA.

This patent has sixteen patent family members in sixteen countries.

Summary for Patent: 9,308,195

Title:	Non-aqueous taxane formulations and methods of using the same
Abstract:	Non-aqueous, ethanol-free taxane formulations are provided. Formulations of embodiments of the invention include a taxane, an oil, a non-ionic surfactant, a non-aqueous solvent, and an organic acid component, wherein the organic acid component is soluble in the non-aqueous solvent and the amount by weight of non-ionic surfactant is equal to or greater than the amount by weight of non-aqueous solvent. Also provided are methods of using the formulations, as well as kits that include the formulations. Non-aqueous, ethanol-free docetaxel formulations are provided. Formulations of embodiments of the invention include docetaxel, an oil, a non-ionic surfactant, a non-aqueous solvent, and an organic acid which is soluble in the non-aqueous solvent and is substantially free of any conjugate base. Also provided are methods of using the formulations, as well as kits that include the formulations.
Inventor(s):	Nabeta; Kiichiro (Tokyo, JP)
Assignee:	Teikoku Pharma USA, Inc. (San Jose, CA)
Application Number:	14/564,384
Patent Claim Types: see list of patent claims	Formulation; Compound; Use; Device;

Drugs Protected by US Patent 9,308,195

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Patent Submitted
Eagle Pharms	DOCETAXEL	docetaxel	SOLUTION;IV (INFUSION)	205934-001	Dec 22, 2015		RX	No	No			Y
Eagle Pharms	DOCETAXEL	docetaxel	SOLUTION;IV (INFUSION)	205934-002	Dec 22, 2015		RX	No	No			Y
Eagle Pharms	DOCETAXEL	docetaxel	SOLUTION;IV (INFUSION)	205934-003	Dec 22, 2015		RX	No	No			Y

Non-Orange Book US Patents Family Members for Patent 9,308,195

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No.	Title	Estimated Patent Expiration
8,940,786	Non-aqueous taxane nanodispersion formulations and methods of using the same
9,763,880	Non-aqueous taxane formulations and methods of using the same

International Patents Family Members for US Patent 9,308,195

Country	Document Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Argentina	092759
Australia	2013327563
Canada	2885930
China	104822262